Abbvie expects to bring endometriosis drug to FDA in 2017
February 10, 2016 at 11:18 AM EST
AbbVie said the endometriosis drug it’s developing with Neurocrine Bioscience will go to the FDA next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.